Trial intelligence / Profile preview

Iron Polymaltose vs Ferrous Sulphate in Pediatric Iron Deficiency Anemia

NCT06742528Recruiting

Start
Jan 2024
Primary completion
Dec 2024
Modality
Polymer-based Nanoparticles, Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

Randomised trial of iron polymaltose in iron deficiency anemia (IDA) (2 arms). Primary endpoint: Increase Of Hemoglobin Level at 8 weeks. Started Jan 2024; status: recruiting.

02

Drugs

iron polymaltose
03

Conditions

iron deficiency anemia (IDA)

Beyond the preview

Go deeper on NCT06742528.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06742528.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call